Low Dose Low-Molecular-Weight Heparin for Thrombosis Prophylaxis: Systematic Review with Meta-Analysis and Trial Sequential Analysis

International guidelines recommend low-molecular-weight heparin (LMWH) as first-line pharmacological option for the prevention of venous thromboembolism (VTE) in many patient categories. Guidance on the optimal prophylactic dose is lacking. We conducted a systematic review with meta-analysis and tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Eck, Ruben J., Bult, Wouter, Wetterslev, Jørn, Gans, Reinold O. B., Meijer, Karina, van der Horst, Iwan C. C., Keus, Frederik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947554/
https://www.ncbi.nlm.nih.gov/pubmed/31766453
http://dx.doi.org/10.3390/jcm8122039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947554/
https://www.ncbi.nlm.nih.gov/pubmed/31766453
http://dx.doi.org/10.3390/jcm8122039

Ejemplares similares